Su Qiu

5.8k total citations · 2 hit papers
38 papers, 4.2k citations indexed

About

Su Qiu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Su Qiu has authored 38 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Su Qiu's work include Cell death mechanisms and regulation (19 papers), ATP Synthase and ATPases Research (11 papers) and Ubiquitin and proteasome pathways (7 papers). Su Qiu is often cited by papers focused on Cell death mechanisms and regulation (19 papers), ATP Synthase and ATPases Research (11 papers) and Ubiquitin and proteasome pathways (7 papers). Su Qiu collaborates with scholars based in United States, China and Japan. Su Qiu's co-authors include Shaomeng Wang, Zaneta Nikolovska‐Coleska, Chao‐Yie Yang, Jeanne A. Stuckey, Junya Masumoto, Naohiro Inohara, Gabriel Núñez, Haiying Sun, Yasunori Ogura and Mathias Chamaillard and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Su Qiu

38 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid

2003 1.0k citations Mathias Chamaillard, Masahito Hashimoto et al. Nature Immunology profile →
Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors

2005 564 citations Ke Ding, Yipin Lu et al. profile →

Peers

Su Qiu

IMMUN

ONCOL

EPIDE

Howard B. Cottam United States

Daniel Kolarich Germany

Liliane Goetsch France

Grzegorz Dubin Poland

Terry L. Bowlin United States

Karl Ziegelbauer Germany

Scott J. Snipas United States

Michael Foley Australia

Howard C. Hang United States

Stephen Ho United States

Howard B. Cottam United States

Su Qiu

2.1k ×0.9

1.5k ×1.2

IMMUN

1.1k ×1.2

594 ×0.8

ONCOL

675 ×1.8

EPIDE

Citations per year, relative to Su Qiu Su Qiu (= 1×) peers Howard B. Cottam

Countries citing papers authored by Su Qiu

Since Specialization

Citations

This map shows the geographic impact of Su Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Qiu more than expected).

Fields of papers citing papers by Su Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Qiu. The network helps show where Su Qiu may publish in the future.

Co-authorship network of co-authors of Su Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Su Qiu. A scholar is included among the top collaborators of Su Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Qiu. Su Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaocheng, Maosheng Cheng, Shuang Chen, et al.. (2025). Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils. Nature Communications. 16(1). 3975–3975. 1 indexed citations

Hu, Jun, Su Qiu, Fan Yang, et al.. (2013). Unique Mechanism of the Interaction between Honey Bee Toxin TPNQ and rKir1.1 Potassium Channel Explored by Computational Simulations: Insights into the Relative Insensitivity of Channel towards Animal Toxins. PLoS ONE. 8(7). e67213–e67213. 7 indexed citations

Lü, Jianfeng, Donna McEachern, Haiying Sun, et al.. (2011). Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment. Molecular Cancer Therapeutics. 10(5). 902–914. 51 indexed citations

Cai, Qian, Haiying Sun, Yuefeng Peng, et al.. (2011). A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment. Journal of Medicinal Chemistry. 54(8). 2714–2726. 213 indexed citations

Zhao, Ruiming, Hui Dai, Su Qiu, et al.. (2011). SdPI, The First Functionally Characterized Kunitz-Type Trypsin Inhibitor from Scorpion Venom. PLoS ONE. 6(11). e27548–e27548. 55 indexed citations

Sun, Haiying, Liu Liu, Jianfeng Lü, et al.. (2011). Potent Bivalent Smac Mimetics: Effect of the Linker on Binding to Inhibitor of Apoptosis Proteins (IAPs) and Anticancer Activity. Journal of Medicinal Chemistry. 54(9). 3306–3318. 31 indexed citations

Sun, Haiying, Liu Liu, Jianfeng Lü, et al.. (2010). Cyclopeptide Smac mimetics as antagonists of IAP proteins. Bioorganic & Medicinal Chemistry Letters. 20(10). 3043–3046. 28 indexed citations

Bai, Longchuan, et al.. (2009). Effect of (-)-gossypol (AT-101) on transcriptional regulation of Noxa and Puma and on Mcl-1-mediated cancer cell resistance to apoptosis. Journal of Clinical Oncology. 27(15_suppl). e14611–e14611. 2 indexed citations

Shangary, Sanjeev, Ke Ding, Su Qiu, et al.. (2008). Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer. Molecular Cancer Therapeutics. 7(6). 1533–1542. 75 indexed citations

10.

Lü, Jianfeng, Longchuan Bai, Haiying Sun, et al.. (2008). SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP. Cancer Research. 68(22). 9384–9393. 174 indexed citations

11.

Sun, Haiying, Jeanne A. Stuckey, Zaneta Nikolovska‐Coleska, et al.. (2008). Structure-Based Design, Synthesis, Evaluation, and Crystallographic Studies of Conformationally Constrained Smac Mimetics as Inhibitors of the X-linked Inhibitor of Apoptosis Protein (XIAP). Journal of Medicinal Chemistry. 51(22). 7169–7180. 69 indexed citations

12.

Sun, Haiying, Zaneta Nikolovska‐Coleska, Chao‐Yie Yang, et al.. (2008). Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics. Accounts of Chemical Research. 41(10). 1264–1277. 132 indexed citations

13.

Zhang, Bin, Zaneta Nikolovska‐Coleska, Yan Zhang, et al.. (2008). Design, Synthesis, and Evaluation of Tricyclic, Conformationally Constrained Small-Molecule Mimetics of Second Mitochondria-Derived Activator of Caspases. Journal of Medicinal Chemistry. 51(23). 7352–7355. 27 indexed citations

14.

Tang, Guozhi, Chao‐Yie Yang, Zaneta Nikolovska‐Coleska, et al.. (2007). Pyrogallol-Based Molecules as Potent Inhibitors of the Antiapoptotic Bcl-2 Proteins. Journal of Medicinal Chemistry. 50(8). 1723–1726. 42 indexed citations

15.

Yi, Hong, Su Qiu, Zhijian Cao, Yingliang Wu, & Wenxin Li. (2007). Molecular basis of inhibitory peptide maurotoxin recognizing Kv1.2 channel explored by ZDOCK and molecular dynamic simulations. Proteins Structure Function and Bioinformatics. 70(3). 844–854. 47 indexed citations

16.

Masumoto, Junya, Kangkang Yang, Sooryanarayana Varambally, et al.. (2006). Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. The Journal of Experimental Medicine. 203(1). 203–213. 176 indexed citations

17.

Chen, Jianyong, Zaneta Nikolovska‐Coleska, Guoping Wang, Su Qiu, & Shaomeng Wang. (2006). Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein. Bioorganic & Medicinal Chemistry Letters. 16(22). 5805–5808. 63 indexed citations

18.

Masumoto, Junya, Kangkang Yang, Sooryanarayana Varambally, et al.. (2006). Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. The Journal of Cell Biology. 172(3). iX–iX. 7 indexed citations

19.

Tanabe, Tsuyoshi, Mathias Chamaillard, Yasunori Ogura, et al.. (2004). Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. The EMBO Journal. 23(7). 1587–1597. 293 indexed citations

20.

Chamaillard, Mathias, Masahito Hashimoto, Yasuo Horie, et al.. (2003). An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nature Immunology. 4(7). 702–707. 1017 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact